A "pause" in use of Johnson & Johnson vaccines isn't expected to have a significant impact on Minnesota's vaccine rollout.
- "We'll see about a 5% or so drop off [in supply] but it will not impact our desire and our nation-leading efforts to get 80% vaccinated," Gov. Tim Walz told reporters.
Driving the news: The FDA recommended that states immediately stop use of the one-dose vaccine following reports that six women — out of a pool of nearly 7 million shot recipients — experienced an "extremely rare" blood clot disorder within weeks of their shot. Go deeper (1 min. read)
- The guidance, issued "out of an abundance of caution," will allow health officials to take a closer look at the data and make a recommendation for identifying and treating at-risk individuals.
Between the lines: The vast majority of doses administered in Minnesota — more than 90% — are Moderna or Pfizer.
- Yes, but: MDH Commissioner Jan Malcolm acknowledged that while the pause is a sign the public health system is working, the headlines could present more challenges for officials' efforts to overcome vaccine hesitancy.
What if means for you: If you are signed up for a Johnson & Johnson shot, the provider should reach out about postponing or rescheduling the appointment.
- If you received yours and experience severe headaches, abdominal pains, leg pain or trouble breathing, call your doctor.
This story first appeared in the Axios Twin Cities newsletter, designed to help readers get smarter, faster on the most consequential news unfolding in their own backyard.
More Twin Cities stories
No stories could be found
Get a free daily digest of the most important news in your backyard with Axios Twin Cities.